Arabic Arabic English English French French German German
dark

Ensysce Biosciences Announces $15 Million Convertible Note Financing

Ensysce Biosciences, Inc. announced today that it has entered into a securities purchase agreement with institutional investors (“Investors”) in the form of senior secured convertible notes Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Which programs are thriving for a five-star performer?

Next Post

VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan

Related Posts
Total
0
Share